Real-time stock & option trading headlines, breaking news, rumors and strategy. Nothing we post constitutes investment advice; we may have positions in markets

Chicago, IL & Austin, Tx
Joined February 2014
Sick of scrolling through our feed for all the premarket news? Get all our posts in a free daily email, sign up here openoutcrier.com
5
4
39
161,679
Open Outcrier retweeted
$ANT - ANTHROPIC PLANS EARLY SHARE SALES AFTER IPO Anthropic is preparing an unconventional lock-up structure, allowing some early investors and employees to sell shares before the traditional 180-day restriction expires. Planned release dates include: 🔸 Day 1: Some shares eligible for sale 🔸 Day 27: Additional shares unlocked 🔸 Day 48: Further shares released The number of shares eligible for sale has not yet been disclosed. The key takeaway: Staggered lock-ups could create selling pressure and volatility shortly after Anthropic's IPO. Source: Anthropic S-1 Filing
47
31
17
205
89,705
$ANT ANTHROPIC PUBLICLY FILES FOR NASDAQ IPO ooc.bz/l/118522
1
2,279
$APO (+0.9% pre) Apollo to buy nearly 10% stake in Abu Dhabi-backed alternative asset manager Mubadala Capital ooc.bz/l/118520
1,907
$MSTR (-1.9% pre) Strategy pauses bitcoin purchases, repurchases $204.9M in STRC stock ooc.bz/l/118517
1,989
$VZ (-0.5% pre) Verizon earnings beat by $0.03, revenue fell short of estimates ooc.bz/l/118515
1,985
$MMYT (+2.2% pre) MakeMyTrip stock rises 4% on profit view despite revenue miss ooc.bz/l/118513
1,853
$MED (+5.3% pre) Medifast (NYSE:MED) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations ooc.bz/l/118511
1
1
1,955
$BOH (+1.0% pre) Bank of Hawaii (NYSE:BOH) Q3 2026 Revenue Miss Offset by Margin Expansion ooc.bz/l/118509
1,967
$ARLP (+3.2% pre) Alliance Resource Partners Q3 profit jumps on record royalty revenues ooc.bz/l/118507
1,885
$XNCR (+33.4% pre) Xencor reports Phase 1 dose data for kidney cancer drug XmAb819 ooc.bz/l/118505
1
1
1,937
$NBTX (+5.6% pre) NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma ooc.bz/l/118502
1,845
$MRNA (-7.3% pre) Moderna’s cancer vaccine is ‘likely’ to get approved. Skeptics question if it will be the best option. ooc.bz/l/118500
1,921
$BNTX (-2.9% pre) BioNTech (BNTX) Reworks Phase 3 Breast Cancer Trial Around New Combination Approach ooc.bz/l/118499
1,830
$AVBP (-2.9% pre) ArriVent reports 44.8% response rate for ADC ARR-217 in CRC patients ooc.bz/l/118497
1
1,831
$AMRN (+4.3% pre) Amarin’s icosapent ethyl shows survival benefit in cancer trial ooc.bz/l/118495
1,781
$AMGN (+0.5% pre) Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer ooc.bz/l/118493
1,778
Open Outcrier retweeted
⏳ JUST 3 DAYS until T4AC Austin! We're bringing together some incredible people from the trading community, including @TheOneLanceB, @edu_trades, @OpenOutcrier, @traderkylec and @SMBCapital! Come for the connections. Stay for the fun. Give back while you're at it. 🎟️ traders4acause.org/austin26/
7
1
14
4,988
$VAI (+7.9% pre) Valor Energy raises $5M for Ohio computing center acquisition ooc.bz/l/118490
1,776